Cargando…

Birth Control in Clinical Trials: Industry Survey of Current Use Practices, Governance, and Monitoring

The Health and Environmental Sciences Institute (HESI) Developmental and Reproductive Toxicology Technical Committee sponsored a pharmaceutical industry survey on current industry practices for contraception use during clinical trials. The objectives of the survey were to improve our understanding o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stewart, J., Breslin, W. J., Beyer, B. K., Chadwick, K., De Schaepdrijver, L., Desai, M., Enright, B., Foster, W., Hui, J. Y., Moffat, G. J., Tornesi, B., Van Malderen, K., Wiesner, L., Chen, C. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2015
Materias:	Clinical Trials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766962/ https://www.ncbi.nlm.nih.gov/pubmed/27042398 http://dx.doi.org/10.1177/2168479015608415

Ejemplares similares

Comparison of rat and rabbit embryo–fetal developmental toxicity data for 379 pharmaceuticals: on the nature and severity of developmental effects
por: Theunissen, Peter T., et al.
Publicado: (2016)

Medical care disruptions during the first six months of the COVID-19 pandemic: the experience of older breast cancer survivors
por: Dilawari, A., et al.
Publicado: (2021)

Phase I trial to investigate the effect of renal impairment on isavuconazole pharmacokinetics
por: Townsend, Robert W., et al.
Publicado: (2017)

Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy
por: van Roozendaal, L. M., et al.
Publicado: (2016)

Pulmonary Penetration of Piperacillin and Tazobactam in Critically Ill Patients
por: Felton, T W, et al.
Publicado: (2014)

De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based study
por: Simons, J. M., et al.
Publicado: (2020)

Limited sampling strategy for prolonged-release tacrolimus in renal transplant patients by use of the dried blood spot technique
por: van Boekel, G. A. J., et al.
Publicado: (2015)

The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression
por: Bryant, Richard J., et al.
Publicado: (2020)

Minimally invasive breast cancer excision using the breast lesion excision system under ultrasound guidance
por: Sanderink, W. B. G., et al.
Publicado: (2020)

Mammographic screening detects low-risk tumor biology breast cancers
por: Drukker, C. A., et al.
Publicado: (2014)

Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer
por: Vriens, B. E. P. J., et al.
Publicado: (2017)

Pilot PET Study to Assess the Functional Interplay Between ABCB1 and ABCG2 at the Human Blood–Brain Barrier
por: Bauer, M, et al.
Publicado: (2016)

Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)
por: de Groot, S., et al.
Publicado: (2015)

SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer
por: Nahleh, Z. A., et al.
Publicado: (2016)

Cross-cultural comparison of breast cancer patients’ Quality of Life in the Netherlands and Japan
por: Fischer, M. J., et al.
Publicado: (2017)

Randomized controlled multicenter trial on the effectiveness of the collagen hemostat Sangustop(®) compared with a carrier-bound fibrin sealant during liver resection (ESSCALIVER study, NCT00918619)
por: Moench, C., et al.
Publicado: (2014)

To which extent do breast cancer survivors feel well informed about disease and treatment 5 years after diagnosis?
por: Herbert, S. L., et al.
Publicado: (2020)

Sertraline concentrations in pregnant women are steady and the drug transfer to their infants is low
por: Heinonen, E., et al.
Publicado: (2021)

Application of a decision analytic framework for adoption of clinical trial results: are the data regarding TARGIT-A IORT ready for prime time?
por: Esserman, L. J., et al.
Publicado: (2014)

Overcoming difficulties with equipoise to enable recruitment to a randomised controlled trial of partial ablation vs radical prostatectomy for unilateral localised prostate cancer
por: Elliott, Daisy, et al.
Publicado: (2018)

Topical Ocular Anti-TNFα Agent Licaminlimab in the Treatment of Acute Anterior Uveitis: A Randomized Phase II Pilot Study
por: Pasquali, Theodore A., et al.
Publicado: (2022)

The impact of age on patient-reported outcomes after oncoplastic versus conventional breast cancer surgery
por: Ritter, M., et al.
Publicado: (2021)

Pathologic complete response of ductal carcinoma in situ to neoadjuvant systemic therapy in HER2-positive invasive breast cancer patients: a nationwide analysis
por: Ploumen, Roxanne A. W., et al.
Publicado: (2023)

Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms
por: Drukker, C. A., et al.
Publicado: (2014)

Testing the effectiveness of a transdiagnostic treatment approach in reducing violence and alcohol abuse among families in Zambia: study protocol of the Violence and Alcohol Treatment (VATU) trial
por: Kane, J. C., et al.
Publicado: (2017)

Combination Therapy With Zoledronic Acid and FES‐Row Training Mitigates Bone Loss in Paralyzed Legs: Results of a Randomized Comparative Clinical Trial
por: Morse, L R, et al.
Publicado: (2019)

CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin‐C vs surgical management in low‐risk non‐muscle‐invasive bladder cancer
por: Mostafid, A. Hugh, et al.
Publicado: (2020)

LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo-Controlled Trial
por: Zambrowicz, B, et al.
Publicado: (2012)

Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy
por: de Groot, A. F., et al.
Publicado: (2019)

Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)
por: McMurray, John J.V., et al.
Publicado: (2013)

The influence of neoadjuvant chemotherapy on complications of immediate DIEP flap breast reconstructions
por: Beugels, J., et al.
Publicado: (2019)

Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
por: Goadsby, Peter J, et al.
Publicado: (2019)

Self Help Plus: study protocol for a cluster-randomised controlled trial of guided self-help with South Sudanese refugee women in Uganda
por: Brown, F. L., et al.
Publicado: (2018)

Randomised clinical trial: a phase 1, dose‐ranging study of the anti‐matrix metalloproteinase‐9 monoclonal antibody GS‐5745 versus placebo for ulcerative colitis
por: Sandborn, W. J., et al.
Publicado: (2016)

Effect of different limb lengths on quality of life, eating patterns and gastrointestinal symptoms after Roux‐en‐Y gastric bypass in superobese patients: randomized study
por: Nergård, B. J., et al.
Publicado: (2020)

Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study
por: van Nes, J. G. H., et al.
Publicado: (2012)

Paclitaxel injection concentrate for nanodispersion versus nab-paclitaxel in women with metastatic breast cancer: a multicenter, randomized, comparative phase II/III study
por: Jain, Minish M., et al.
Publicado: (2016)

Implementing a patient decision aid, a process evaluation of a large-scale pre- and post-implementation trial
por: Raphael Daniela, D. B., et al.
Publicado: (2020)

Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98
por: Alkner, S., et al.
Publicado: (2017)

Impact of preoperative breast MRI on 10-year survival of patients included in the Swedish randomized multicentre POMB trial
por: Gonzalez, V, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uib8q0f1ceb77ak431mnlgs0k3